» Articles » PMID: 35909638

Race-Ethnic Differences of ST-Elevation Myocardial Infarction: Findings from a New York Health System Registry

Overview
Journal Ethn Dis
Date 2022 Aug 1
PMID 35909638
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Race and ethnicity are major considerations in the incidence, management, and long-term outcome of ST-elevation myocardial infarction (STEMI) in the United States, but there is limited existing comparative data.

Methods: We assembled a registry in a health system serving Bronx, NY of STEMI patients from 2008-2014 and analyzed differences in presentation, treatment and mortality between Hispanic/Latino (H/L), non-Hispanic Black (NHB) and non-Hispanic White (NHW). Upon discharge post-treatment for STEMI, all patients were followed for a median of 4.4 years (interquartile range 2.5, 6.0). Out of 966 STEMI patients, mean age was 61 years, 46% were H/L and 65% were male. H/Ls and NHBs had a higher prevalence of hypertension and diabetes mellitus than their NHW counterparts, coinciding with a lower socioeconomic status (SES).

Results: The number of critically diseased vessels found at cardiac catheterization and mean troponin levels did not vary by race-ethnicity; neither did the adjusted hazard ratios (HR) for death. However, age-sex adjusted rates of general hospital readmission were higher in NHBs vs NHWs (HR 1.30, P=.03). Age-sex adjusted cardiovascular readmissions rates were higher in H/Ls than NHWs (HR 1.42, P=.03). Age-sex adjusted heart failure readmissions were increased for both H/Ls (HR 2.14, P=.01) and NHBs (HR 2.12, P=.02) over NHWs.

Conclusions: Among STEMI patients, a higher prevalence of modifiable cardiovascular risk factors and a lower SES was seen among NHBs and H/Ls compared to NHWs. Despite similar coronary disease severity and in-hospital death, NHBs and H/Ls had a greater risk of general, cardiovascular and heart failure readmissions post-STEMI compared to NHWs.

Citing Articles

Ethnic disparities in STEMI outcomes among older adults: a comparative study of bedouins and jews.

Shashar S, Zeldetz V, Shalev A, Barret O, Press Y, Shamia D Int J Equity Health. 2025; 24(1):66.

PMID: 40065403 PMC: 11895306. DOI: 10.1186/s12939-025-02427-0.


What Women with HIV Know about Heart Health and Cardiovascular Risk and Intervention Preferences.

Duthely L, Satish S, Kedia S, Vilchez L, Valls P, Larson M Int J Environ Res Public Health. 2024; 21(9).

PMID: 39338032 PMC: 11431290. DOI: 10.3390/ijerph21091149.


Factors associated with complications in ST-elevation myocardial infarction: a single-center experience.

Mavungu Mbuku J, Mukombola Kasongo A, Goube P, Miltoni L, Nkodila Natuhoyila A, Mbuyamba-Kabangu J BMC Cardiovasc Disord. 2023; 23(1):468.

PMID: 37726694 PMC: 10510166. DOI: 10.1186/s12872-023-03498-z.


Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results.

Tyczynski M, Kern A, Buller P, Wanha W, Gil R, Bil J J Clin Med. 2023; 12(16).

PMID: 37629356 PMC: 10455238. DOI: 10.3390/jcm12165313.

References
1.
Karetnikova V, Gruzdeva O, Uchasova E, Osokina A, Barbarash O . Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case-control study. BMC Endocr Disord. 2016; 16(1):31. PMC: 4888504. DOI: 10.1186/s12902-016-0108-8. View

2.
Hannan E, Racz M, Walford G, Clark L, Holmes D, King 3rd S . Differences in utilization of drug-eluting stents by race and payer. Am J Cardiol. 2007; 100(8):1192-8. DOI: 10.1016/j.amjcard.2007.05.039. View

3.
Diez Roux A, Merkin S, Arnett D, Chambless L, Massing M, Nieto F . Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001; 345(2):99-106. DOI: 10.1056/NEJM200107123450205. View

4.
Slater J, Selzer F, Dorbala S, Tormey D, Vlachos H, Wilensky R . Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2003; 92(7):773-8. DOI: 10.1016/s0002-9149(03)00881-6. View

5.
Forouhi N, Sattar N . CVD risk factors and ethnicity--a homogeneous relationship?. Atheroscler Suppl. 2006; 7(1):11-9. DOI: 10.1016/j.atherosclerosissup.2006.01.003. View